MARQUEE Trial - Dr. Ron Burkes

Dr. Ron Burkes with commentary on Abstract #3410: A randomized, double-blind, placebo-controlled, phase 3 trial of tivantinib (ARQ 197) plus erlotinib versus placebo plus erlotinib in previously treat... Author: oncologyeducation Added: 10/07/2013
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts